The global Cough Syrup market size was valued at USD 5500 Million in 2021 growing at the CAGR of 3.4% from 2022 to 2032. Cough syrups are sweet medicated liquids used to relieve coughing that’s caused by an upper respiratory tract infection (URTI), as well as other conditions like asthma or lung diseases. They’re typically split into two categories – those for a dry cough and a chesty cough.
- The rise in respiratory disorders
The rise in respiratory disorders is attributed to the increase in air pollution, sedentary lifestyles, and smoking. Cough syrup is a medication used to treat coughing and sore throat. It is available in both over-the-counter and prescription forms. Cough syrup is commonly used to treat upper respiratory tract infections, such as the common cold, bronchitis, and sinusitis.
- Increase in the geriatric population
- Immense air pollution
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016501
Key Highlights:
- The global Cough Syrup market size was valued at USD 5500 Million in 2021 growing at the CAGR of 3.4% from 2022 to 2032.
- North America dominated the market in 2021
- Asia Pacific is expected to grow at a highest CAGR from 2022 to 2032
Key Players
The Cough Syrup market report gives comprehensive information about the company and its past performance. The report also provide a detail market share analysis along with product benchmarking with key developments.
The key players profiled in the report are:
- Abbott Laboratories
- Acella Pharmaceuticals, LLC
- GlaxoSmithKline plc
- Johnson & Johnson services Inc.
- Merck KgaA
- Novartis International AG
- Pfizer Inc
- Procter & Gamble
- Reckitt Benckiser Group Plc
- Sanofi
The Global Cough Syrup Logistic report also includes information on company profiles, product descriptions, revenue, market share data, and contact details for several regional, global, and local companies. Due to increased technological innovation, R&D, and M&A operations in the sector, the market is becoming more popular in particular niche sectors. Additionally, a large number of regional and local vendors in the Cough Syrup market provide specialised product offerings according to geographical regions in keeping with the global manufacturing footprint. Due to the reliability, quality, and technological modernity of the worldwide suppliers, it is difficult for the new market entrants to compete.
COVID Impact
In terms of COVID 19 impact, the Cough Syrup market report also includes the following data points:
- COVID19 Impact on Cough Syrup market size
- End-User/Industry/Application Trend, and Preferences
- Government Policies/Regulatory Framework
- Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
- Opportunity in the Cough Syrup market
Get a Free Sample Copy of This Report @ https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016501
Scope of the Report:
Market Segment By Product Type:
- Expectorants
- Cough Suppressants/Antitussives
- Combination Medications
Market Segment By Age Group:
- Pediatric
- Adult
Market Segment By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
For more information: https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016501
Key Region/ Countries Covered
- North America (US, Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of MEA)
- Latin America (Mexico, Brazil, Argentina, Rest of Latin America)
The Asia-Pacific region generated the most revenue and is projected to continue its dominance through. This is attributable to the ease of availability of cough syrups at retail pharmacies, an increase in the geriatric population, and less stringent laws regarding the abuse of cough & cold medicines in the region. However, LAMEA is expected to experience the highest CAGR during the forecast period as governments invest in the development of healthcare infrastructure and the incidence of respiratory disorders rises.
Reasons to Buy this Report:
- Detail analysis of the impact of market drivers, restraints, and oppotunities
- Competitive Intelligence providing the understanding about the ecosystem
- Details analysis of Total Addressable Market (TAM) of your products
- Investment Pockets and New Business Opportunities
- Demand-supply gap analysis
- Strategy Planning
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.
Contact Us:
Evolve Business Intelligence
India
Contact: +1 773 644 5507 (US) / +441163182335 (UK)
Email: sales@evolvebi.com
Website: www.evolvebi.com
